Analystreport

Atara Biotherapeutics Inc (NASDAQ: ATRA) had its "buy" rating re-affirmed by analysts at William Blair.

Atara Biotherapeutics, Inc.  (ATRA) 
Last atara biotherapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.atarabio.com/investor-relations